LYKA LABS
|
The Current P/E Ratio of LYKA LABS is 52.34.
Share Price | ₹116.4 | Jun 06,2025 |
Market Cap | ₹415.4 Cr | |
Earnings-TTM | ₹7.9 Cr | TTM-Consolidated Results |
Price/Earnings | 52.34x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of LYKA LABS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹415.4 Cr] as on Jun 06,2025
(/) Earnings [ ₹7.9 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 52.34x ]
Thus, for LYKA LABS , the investors are currently willing to pay 52.34 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of LYKA LABS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of LYKA LABS over the last five years.
Historical PE (Price/Earnings) ratio chart of LYKA LABS
PE Ratio Performance Analysis for LYKA LABS
- LYKA LABS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.00x.
- LYKA LABS 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LYKA LABS 's p/e ratio peaked in Mar2022 at 9.98x.
- LYKA LABS 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does LYKA LABS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
LYKA LABS | 7.94 | 52.34 | 415.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 36.71 | 403,076.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 79.38 | 173,924.0 |
CIPLA LTD | 5,291.05 | 22.95 | 121,456.0 |
TORRENT PHARMACEUTICALS LTD | 1,911.00 | 55.87 | 106,761.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 19.32 | 110,197.0 |
MANKIND PHARMA LTD | 2,003.22 | 48.47 | 97,097.4 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 20.93 | 96,598.5 |
LUPIN LTD | 3,306.26 | 27.62 | 91,302.6 |
AUROBINDO PHARMA LTD | 3,515.26 | 19.18 | 67,413.6 |
ABBOTT INDIA LTD | 1,414.44 | 47.70 | 67,468.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs LYKA LABS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 19.18x |
Max industry PE | 79.38x |
Median industry PE | 36.71x |
Average industry PE | 39.13x |
You may also like the below Video Courses